Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cardiotoxicity debated for anthracyclines and trastuzumab in breast cancer.

× No keyword cloud information.

9 in total

1. Predictors of late-onset heart failure in breast cancer patients treated with doxorubicin.

Authors: Angel Qin; Cheryl L Thompson; Paula Silverman
Journal: J Cancer Surviv Date: 2014-10-24 Impact factor: 4.442

Review 2. Efficacy and mechanism of action of the tyrosine kinase inhibitors gefitinib, lapatinib and neratinib in the treatment of HER2-positive breast cancer: preclinical and clinical evidence.

Authors: Mariana Segovia-Mendoza; María E González-González; David Barrera; Lorenza Díaz; Rocío García-Becerra
Journal: Am J Cancer Res Date: 2015-08-15 Impact factor: 6.166

3. Correlation of HER2 codon 655 polymorphism with cardiotoxicity risk in Chinese HER2-positive breast cancer patients undergoing epirubicin/cyclophosphamide followed by docetaxel plus trastuzumab adjuvant chemotherapy.

Authors: Lun Tan; Xinyu Su; Xun Li; Hai Li; Bo Hu
Journal: Int J Clin Exp Pathol Date: 2020-02-01

4. Effects of 5-fluorouracil on morphology, cell cycle, proliferation, apoptosis, autophagy and ROS production in endothelial cells and cardiomyocytes.

Authors: Chiara Focaccetti; Antonino Bruno; Elena Magnani; Desirée Bartolini; Elisa Principi; Katiuscia Dallaglio; Eraldo O Bucci; Giovanna Finzi; Fausto Sessa; Douglas M Noonan; Adriana Albini
Journal: PLoS One Date: 2015-02-11 Impact factor: 3.240

Review 5. Stem cell therapy and breast cancer treatment: review of stem cell research and potential therapeutic impact against cardiotoxicities due to breast cancer treatment.

Authors: Thomas E Sharp; Jon C George
Journal: Front Oncol Date: 2014-11-03 Impact factor: 6.244

6. Protocol update and preliminary results of EACVI/HFA Cardiac Oncology Toxicity (COT) Registry of the European Society of Cardiology.

Authors: Patrizio Lancellotti; Maurizio Galderisi; Erwan Donal; Thor Edvardsen; Bogdan A Popescu; Dimitrios Farmakis; Gerasimos Filippatos; Gilbert Habib; Chiara Lestuzzi; Ciro Santoro; Marie Moonen; Guy Jerusalem; Maryna Andarala; Stefan D Anker
Journal: ESC Heart Fail Date: 2017-05-02

7. Bragatston study protocol: a multicentre cohort study on automated quantification of cardiovascular calcifications on radiotherapy planning CT scans for cardiovascular risk prediction in patients with breast cancer.

Authors: Marleen J Emaus; Ivana Išgum; Sanne G M van Velzen; H J G Desirée van den Bongard; Sofie A M Gernaat; Nikolas Lessmann; Margriet G A Sattler; Arco J Teske; Joan Penninkhof; Hanneke Meijer; Jean-Philippe Pignol; Helena M Verkooijen
Journal: BMJ Open Date: 2019-07-27 Impact factor: 2.692

8. Machine Learning Enables Accurate and Rapid Prediction of Active Molecules Against Breast Cancer Cells.

Authors: Shuyun He; Duancheng Zhao; Yanle Ling; Hanxuan Cai; Yike Cai; Jiquan Zhang; Ling Wang
Journal: Front Pharmacol Date: 2021-12-17 Impact factor: 5.810

Review 9. Animal models in studies of cardiotoxicity side effects from antiblastic drugs in patients and occupational exposed workers.

Authors: Monica Lamberti; Giancarlo Giovane; Elpidio M Garzillo; Franca Avino; Antonia Feola; Stefania Porto; Vincenzo Tombolini; Marina Di Domenico
Journal: Biomed Res Int Date: 2014-02-19 Impact factor: 3.411

9 in total